6 March 2024
Braveheart Investment Group Plc
("Braveheart", the "Company" or the "Group")
Acquisition of further interest in Autins Group plc
Braveheart Investment Group (AIM: BRH), announces that between 4 March 2024 and 5 March 2024, the Company has purchased a further 4,000,000 ordinary shares in Autins Group plc ("Autins") at an average price of 8 pence per share for a total cash consideration of £320,000. Following these purchases, Braveheart now holds 23.42% per cent. of the issued share capital of Autins.
Autins' shares are admitted to trading on AIM (AIM: AUTG) and the company specialises in solving acoustic and thermal problems in the automotive industry and other specialist applications. The growth of electric vehicle production has created new opportunities for Autins who now supply vehicle producers including: JLR, Nissan, BMW, Aston Martin, Lotus, Lamborghini and Bentley; as well as Tier 1 automotive suppliers: Draxlmaier, Kasai, Treves, Novares, Mergon and Yangfeng. In the year ended 30 September 2023, Autins made a loss before tax of £1.04 million on revenue of approximately £22.7 million with net assets of approximately £10.8 million.
The Board continues to seek investment opportunities, both within its existing portfolio and from outside. The Braveheart Board considers this investment to be a strategic investment and thus an important addition to the Group's portfolio.
For further information:
| Braveheart Investment Group plc | Tel: 01738 587555 |
| Trevor Brown, Chief Executive Officer Viv Hallam, Executive Director | |
| | |
| Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
| James Reeve / George Payne | |
| | |
| Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
| Duncan Vasey / Lucy Williams | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.